Medical Research Council

Company

Related News

Ketamine's Therapeutic Benefits Not Linked to Psychedelic Effects in Alcohol Use Disorder

New research challenges the theory that ketamine's psychedelic effects drive its therapeutic benefits for alcohol use disorder. A study of 96 participants found no link between ketamine's psychoactive experiences and improved abstinence rates. The findings suggest other mechanisms, such as brain network alterations, may explain ketamine's effectiveness in treating addiction.

Related Clinical Trials

NCT ID Title Status Phase
NCT07339982

Supermarket Labelling and Taxation Study

RECRUITING NA
NCT07300683

Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma

RECRUITING PHASE1
NCT07207057

Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial

RECRUITING PHASE3
NCT07103681

White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)

RECRUITING
NCT06806501

Muscle Mass, Quality, and the Menopause: Sex-specific Strategies to Mitigate Sarcopenia in Ageing Populations

RECRUITING
NCT06786936

Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

RECRUITING
NCT06729606

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

COMPLETED PHASE3
NCT06729593

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

COMPLETED PHASE3
NCT06678022

Use of Unmanned Air Vehicles (Medical Drones) to Overcome Geographical Barriers to Delivery of Anti-Retroviral Therapy and Biological Samples

RECRUITING NA
NCT06676384

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

RECRUITING PHASE4